Why the study?
Does dipyridamole stress echocardiography predict cardiac events in hypertensive patients with chest pain and unknown CAD?
Does dipyridamole stress echocardiography predict cardiac events in hypertensive patients with chest pain and unknown CAD?
Dipyridamole stress echocardiography is a safe and effective tool for risk stratification in hypertensive patients with chest pain and unknown CAD, strongly predicting future cardiac events.
No takes yet. Share an insight, caveat, or question.
May aid risk stratification in hypertensive patients with chest pain; leaves open confirmation in randomized trials.
Cortigiani et al. (1998) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: